Envoy Medical, Inc. - 8-K Filing
Envoy Medical failed to maintain Nasdaq's $1.00 minimum bid price requirement for continued listing on the Capital Market as of May 18, 2026 but was granted an additional 180-day compliance period until November 16, 2026. The company plans to address this by potentially implementing a reverse stock split. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)
Tickers: $COCH